Suburban Research Associates is seeking volunteers to participate in a heart health study testing a new investigational medicine for people living with or at risk for heart disease.
Heart Disease
Age Range:
18
Gender:
Male and Female
Location:
West Chester, Pennsylvania
About the Study
This study is designed to assess the effect of the investigational medication compared with placebo in reducing the risk of major cardiovascular events in participants with established ASCVD or those at high risk for a first ASCVD event.
Qualifications
You may qualify if you’ve already had a heart or circulation problem, such as:
- A heart attack or serious heart-related event in the past year
- A stroke caused by blocked blood vessels in the past year
- A procedure to improve blood flow in your legs because of poor circulation
OR
You may qualify if you have not had a major event yet, but your doctor has told you that you’re at higher risk because of things like:
- High cholesterol that hasn’t come down enough with medication
- Plaque buildup in your heart, neck, or leg arteries
- A high calcium score on a heart scan
- Diabetes with complications
- Reduced kidney function
*Further qualifications may apply
FEATURED STUDIES
Uncontrolled Hypertension
Adults 18–65 with a history of high blood pressure that remains elevated despite treatment may qualify for a study evaluating
Type 2 Diabetes
Adults with type 2 diabetes who have not achieved adequate blood sugar control despite multiple treatments may qualify for a
Weight Management
Adults 18 years and older may qualify for a study evaluating an investigational once-weekly study medication for weight management in
Depression
Are you between 18 and 65 years old and being treated for depression? Even if your symptoms have improved, you
Monotherapy GAD Study
Suburban Research Associates is currently seeking participants 18 years or older who are struggling with generalized anxiety disorder for a
Lyme Disease Prevention
Suburban Research Associates in West Chester, PA is conducting a research study focused on Lyme disease prevention.